Olaparib Delays Progression in BRCA-Mutated Pancreatic Cancer Olaparib Delays Progression in BRCA-Mutated Pancreatic Cancer

"It is our duty to search for this genetic mutation in all patients with metastatic pancreatic cancer so we can identify those people who can benefit," says Suzanne Cole, UT Southwestern Medical Center.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news